MYRIAD GENETICS, INC. Current Assets
MYRIAD GENETICS, INC. (MYGN) had Current Assets of $289.00 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-31
- 2026-06-30: Assets, Current $289.00M.
- 2026-03-31: Assets, Current $312.80M.
- 2025-12-31: Assets, Current $332.60M.
- 2025-09-30: Assets, Current $344.80M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $289.00M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $312.80M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $332.60M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $344.80M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $284.30M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $287.20M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $298.00M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $293.20M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $291.60M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $290.30M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $313.60M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $265.40M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $294.30M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $261.60M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $274.60M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $352.30M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $367.10M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $427.40M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $484.80M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $498.90M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $538.90M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $329.20M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $389.40M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $394.50M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $331.70M 10-KT · filed 2021-03-16 | |
| 2020-03-31 | $355.20M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $365.30M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $329.50M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $348.60M 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $342.90M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $336.80M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $341.90M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $327.60M 10-K · filed 2019-08-13 | $326.40M 10-K · filed 2018-08-24 |
| 2018-03-31 | $331.50M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $327.00M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $325.60M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $301.70M 10-K · filed 2018-08-24 | $317.10M 10-K · filed 2017-08-09 |
| 2017-03-31 | $348.30M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $341.60M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $322.90M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $314.50M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $372.40M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $375.50M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $307.30M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $283.60M 10-K · filed 2016-08-10 | |
| 2015-03-31 | $282.42M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $320.09M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $335.37M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $322.40M 10-K · filed 2015-08-12 | $322.42M 10-K · filed 2014-08-13 |
| 2014-03-31 | $338.16M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $454.51M 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $458.68M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $483.99M 10-K · filed 2014-08-13 | |
| 2013-03-31 | $447.70M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $457.33M 10-Q · filed 2013-02-06 | |
| 2012-09-30 | $435.13M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $422.49M 10-K · filed 2013-08-14 | |
| 2012-03-31 | $418.67M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $432.44M 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $418.48M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $418.26M 10-K · filed 2012-08-15 | |
| 2011-03-31 | $415.61M 10-Q · filed 2011-05-04 | |
| 2010-12-31 | $444.81M 10-Q · filed 2011-02-01 | |
| 2010-09-30 | $491.85M 10-Q · filed 2010-11-03 | |
| 2010-06-30 | $473.98M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |